(a) point-of-care CD4 testing by non-laboratory staff compared to conventional laboratory-based testing by professional laboratory staff; (b) point-of-care CD4 testing by non-laboratory staff compared to point-of-care CD4 testing by professional laboratory staff; the shaded box represents +/- 50 cells/ul in (a) and (b). (c) sensitivity of correctly classifying patients below a CD4 threshold of 350 cells/ul; (d) specificity of correctly classifying patients above a CD4 threshold of 350 cells/ul.</p
Measurement of CD4+ T-lymphocytes (CD4) is a crucial parameter in the management of HIV patients, pa...
To evaluate the accuracy of the PIMA point-of-care CD4 analyzer (PIMA) under field conditions in com...
INTRODUCTION: Point-of-care (POC) CD4 testing can improve access to treatment by enabling decentrali...
Red forest plot and line indicate the overall pooled error rate. Blue forest plots indicate studies ...
(a) point-of-care ALT testing by non-laboratory staff compared to conventional laboratory-based test...
Measuring CD4 counts remains an important component of HIV care. The Visitect CD4 is the first instr...
Measuring CD4 counts remains an important component of HIV care. The Visitect CD4 is the first inst...
<p>(a) in patients not receiving routine CD4 count monitoring (CDM: 20% >250 cells/mm3). (b) in pati...
<p>At the time of HIV diagnosis and immunologic staging, the model captures both the “true CD4 count...
Accurate, inexpensive point-of-care CD4+ T cell testing technologies are needed that can deliver CD4...
Currently 50% of ART eligible patients are not yet receiving life-saving antiretroviral therapy (ART...
<p>Two-by-two table of the BD FACSPresto compared with FACSCount using a CD4 threshold of 500 cells ...
Background: Point-of-care (POC) CD4 testing increases patient accessibility to assessment of antiret...
To evaluate the accuracy of the PIMA point-of-care CD4 analyzer (PIMA) under field conditions in com...
Background: Accurate, inexpensive point-of-care CD4+ T cell testing technologies are needed that can...
Measurement of CD4+ T-lymphocytes (CD4) is a crucial parameter in the management of HIV patients, pa...
To evaluate the accuracy of the PIMA point-of-care CD4 analyzer (PIMA) under field conditions in com...
INTRODUCTION: Point-of-care (POC) CD4 testing can improve access to treatment by enabling decentrali...
Red forest plot and line indicate the overall pooled error rate. Blue forest plots indicate studies ...
(a) point-of-care ALT testing by non-laboratory staff compared to conventional laboratory-based test...
Measuring CD4 counts remains an important component of HIV care. The Visitect CD4 is the first instr...
Measuring CD4 counts remains an important component of HIV care. The Visitect CD4 is the first inst...
<p>(a) in patients not receiving routine CD4 count monitoring (CDM: 20% >250 cells/mm3). (b) in pati...
<p>At the time of HIV diagnosis and immunologic staging, the model captures both the “true CD4 count...
Accurate, inexpensive point-of-care CD4+ T cell testing technologies are needed that can deliver CD4...
Currently 50% of ART eligible patients are not yet receiving life-saving antiretroviral therapy (ART...
<p>Two-by-two table of the BD FACSPresto compared with FACSCount using a CD4 threshold of 500 cells ...
Background: Point-of-care (POC) CD4 testing increases patient accessibility to assessment of antiret...
To evaluate the accuracy of the PIMA point-of-care CD4 analyzer (PIMA) under field conditions in com...
Background: Accurate, inexpensive point-of-care CD4+ T cell testing technologies are needed that can...
Measurement of CD4+ T-lymphocytes (CD4) is a crucial parameter in the management of HIV patients, pa...
To evaluate the accuracy of the PIMA point-of-care CD4 analyzer (PIMA) under field conditions in com...
INTRODUCTION: Point-of-care (POC) CD4 testing can improve access to treatment by enabling decentrali...